Considerations for understanding protein measurements: Identification of formation, degradation and more pathological relevant epitopes.


Journal

Clinical biochemistry
ISSN: 1873-2933
Titre abrégé: Clin Biochem
Pays: United States
ID NLM: 0133660

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 21 06 2021
revised: 06 08 2021
accepted: 23 08 2021
pubmed: 29 8 2021
medline: 28 12 2021
entrez: 28 8 2021
Statut: ppublish

Résumé

There is a need for precision medicine and an unspoken promise of an optimal approach for identification of the right patients for value-based medicine based on big data. However, there may be a misconception that measurement of proteins is more valuable than measurement of fewer selected biomarkers. In population-based research, variation may be somewhat eliminated by quantity. However, this fascination of numbers may limit the attention to and understanding of the single. This review highlights that protein measurements (with collagens as examples) may mean different things depending on the targeted epitope - formation or degradation of tissues, and even signaling potential of proteins. PubMed was searched for collagen, neo-epitope, biomarkers. Ample examples of assays with specific epitopes, either pathological such as HbA1c, or domain specific such as pro-peptides, which total protein arrays would not have identified were evident. We suggest that big data may be considered as the funnel of data points, in which most important parameters will be selected. If the technical precision is low or the biological accuracy is limited, and we include suboptimal quality of biomarkers, disguised as big data, we may not be able to fulfill the promise of helping patients searching for the optimal treatment. Alternatively, if the technical precision of the total protein quantification is high, but we miss the functional domains with the most considerable biological meaning, we miss the most important and valuable information of a given protein. This review highlights that measurements of the same protein in different ways may provide completely different meanings. We need to understand the pathological importance of each epitope quantified to maximize protein measurements.

Identifiants

pubmed: 34453894
pii: S0009-9120(21)00228-9
doi: 10.1016/j.clinbiochem.2021.08.007
pii:
doi:

Substances chimiques

Epitopes 0
Proteins 0
Collagen 9007-34-5

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

11-24

Informations de copyright

Copyright © 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Auteurs

M A Karsdal (MA)

Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark. Electronic address: mk@nordicbio.com.

F Genovese (F)

Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark.

D G K Rasmussen (DGK)

Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark.

A C Bay-Jensen (AC)

Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark.

J H Mortensen (JH)

Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark.

S Holm Nielsen (S)

Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark.

N Willumsen (N)

Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark.

C Jensen (C)

Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark.

T Manon-Jensen (T)

Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark.

L Jennings (L)

Novartis, Basel, Switzerland.

A L Reese-Petersen (AL)

Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark.

K Henriksen (K)

Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark.

J M Sand (JM)

Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark.

C Bager (C)

Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark.

D J Leeming (DJ)

Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH